For years, we’ve been told that lowering “bad” cholesterol is the key to preventing heart attacks. But what if inflammation is an even bigger threat, especially if you’re already taking a statin?
A large analysis published in The Lancet looked at this exact question. Researchers studied 31,245 patients from three major clinical trials, PROMINENT, REDUCE-IT, and STRENGTH, all of whom were already taking statins to lower cholesterol.
Understanding the Link Between Inflammation, Cholesterol, and Heart Health This study examined whether inflammation or cholesterol levels are better predictors of heart disease and death in people already taking statins, a common cholesterol-lowering medication. Researchers analyzed data from 31,245 patients across three major...
As people get older, their risk of heart disease tends to rise. Doctors usually look at things like blood pressure, cholesterol, and lifestyle to estimate that risk. But scientists are also searching for biological markers—substances in the blood that might help identify who is most likely to develop heart problems. A new study found that both vitamin D levels and a...
Many people with type 2 diabetes (T2D) take medications to control blood sugar after initial treatment with metformin. But not all options may be equal when it comes to heart health. A large study published in JAMA Network Open looked at whether three common diabetes medicines affect the risk of serious heart problems, including heart attack, stroke, heart failure,...
A large study has found that medications like Ozempic, Wegovy, and Trulicity, which are used to treat diabetes and aid weight loss, may also reduce the risk of heart attacks, strokes, and death from heart disease. These findings, published in the Journal of the American College of Cardiology in 2025, could change how doctors use these medicines for people with...
What Did the Research Discover? Researchers investigated whether high blood pressure (hypertension) and the use of antihypertensive medications affect the risk of developing Alzheimer’s disease (AD) and other types of dementia in older adults. This study combined data from 31,250 participants across 14 countries, with an average starting age of 72 years. The...